Vir Biotechnology
VIR
VIR
213 hedge funds and large institutions have $559M invested in Vir Biotechnology in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 83 increasing their positions, 61 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
8% less capital invested
Capital invested by funds: $605M → $559M (-$46M)
9% less funds holding
Funds holding: 233 → 213 (-20)
46% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 41
Holders
213
Holding in Top 10
3
Calls
$1.9M
Puts
$961K
Top Buyers
| 1 | +$65.1M | |
| 2 | +$9.31M | |
| 3 | +$6.76M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.45M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
+$2.95M |
Top Sellers
| 1 | -$3.24M | |
| 2 | -$3.02M | |
| 3 | -$2.38M | |
| 4 |
D.E. Shaw & Co
New York
|
-$2.37M |
| 5 |
BlackRock
New York
|
-$1.96M |
